跳至主要内容
临床试验/ACTRN12620000066987
ACTRN12620000066987已完成未知

Optimising the radiotherapy planning and treatment for anal cancer

Austin Health0 个研究点目标入组 11 人开始时间: 2020年1月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Austin Health
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion Criteria
  • Histologically confirmed SCC Anal Canal confined to the pelvis
  • ECOG Performance Status 0-2
  • Age > 18 yrs;
  • competent to give written informed consent

排除标准

  • Contraindication to MRI such as
  • cochlear implants
  • some cardiac stents
  • claustrophobia
  • Allergy to Gadolinium (DCE scan)
  • Contraindication to PET such as
  • Poor renal function
  • Gross metastatic disease
  • Other illness that would impair ability to remain still/stable during treatment
  • Healing/bleeding disorder
  • Previous radiotherapy
  • Unable to attend for the full course of treatment or trial related visits.

研究者

发起方
Austin Health

相似试验